January 21, 2014

Global vaccine report tackles details on animal vaccines

Research and Markets' "2013 Report on the International Animal/Veterinary Vaccines Market - Global Forecast to 2018" discusses that the animal vaccines market studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for veterinary administration.

The global market, by products, is further segmented into seven segments, namely, companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other veterinary vaccines.

Livestock vaccines and porcine vaccines were two of the largest segments, accounting for 63% of the market share globally in 2012. The livestock vaccines market is further segmented into bovine vaccines and small ruminant vaccines, whereas the companion animal vaccines market is further segmented into canine vaccines and feline vaccines.

By technology, the market has segments like live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. DNA vaccines demonstrate tremendous growth opportunities due to factors such as added thermo-stability, cost effectiveness and easy production, and rapid development against emerging diseases.

The global market will be valued at US$5.8 billion in 2013 and is expected to reach US$8.6 billion by 2018, growing at a healthy Compounded Annual Growth Rate (CAGR) of 8.1% from 2013 to 2018. Increasing investment opportunities in emerging and immature markets, growing prevalence of animal diseases, and increasing incidences of zoonotic diseases in humans are the key factors driving the growth of the market globally.